India, Sept. 7 -- The following biotech stocks reached a 52-week high on September 4, 2026, as various companies reported financial results and anticipated near-term clinical trial readouts.
Pro-Dex Inc. (PDEX)
Pro-Dex develops, designs, and manufactures powered surgical instruments for orthopedic, maxocranial facia, and thoracic procedures.
The company's stock surged over 18% to a 52-week high of $77 in Friday's trade.
The company reported financial results for the full fiscal year of 2026 on Thursday, noting a 16% increase in net sales to $77.5 million. This contributed to the year's profit of $13.7 million, compared to $9 million in the previous fiscal period.
Products marketed by the company include the Helios Pro surgical precisio...